Journal of Ayurveda and Integrated Medical Sciences

2024 Volume 9 Number 12 DECEMBER
Publisherwww.maharshicharaka.in

Clinical trial to evaluate the addon effect of Vimlapana Karma in Dushta Vrana w.s.r. to Varicose Ulcer: A Randomised Controlled Trial

Tuppad V1*, Shilpa PN2
DOI:10.21760/jaims.9.12.3

1* Vanishree Tuppad, Post Graduate Scholar, Dept of Pg Phd Studies in Shalyatantra, Govt Ayurvedic Medical College, Bangalore, Karnataka, India.

2 Shilpa PN, Professor, Dept of Pg Phd Studies in Shalyatantra, Govt Ayurvedic Medical College, Bangalore, Karnataka, India.

Dushta Vrana, associated with delayed healing and correlated with varicose ulcers, arises from venous insufficiency. According to Sushrut Samhita, Ayurvedic treatments like Vimlapana Karma and Jalaukavacharana are emphasized for their wound-healing and anti-inflammatory properties, while Saptopakrama and Shasti Upakrama address Vrana Shopha and Vrana. This study explores the additive effect of Vimlapana Karma on the standard treatment of Jalaukavacharana for Dushta Vrana. Forty patients with Dushta Vrana were randomly assigned to two groups: Group A received wound dressing and Jalaukavacharana, while Group B received Vimlapana Karma and Jalaukavacharana, both over 21 days. Both Group A (Jalaukavacharana) and Group B (Vimlapana Karma with Jalaukavacharana) showed statistically significant improvements (p < 0.001) in ulcer size, edges, exudate, surrounding skin color, and granulation tissue formation. Combining Jalaukavacharana with Vimlapana Karma significantly enhanced wound healing and accelerated recovery in Dushta Vrana (varicose ulcers).

Keywords: Dushta Vrana, Vimlapana Karma, Jalaukavacharana, Saptopakrama, Chronic wounds, Non-healing ulcer

Corresponding Author How to Cite this Article To Browse
Vanishree Tuppad, Post Graduate Scholar, Dept of Pg Phd Studies in Shalyatantra, Govt Ayurvedic Medical College, Bangalore, Karnataka, India.
Email:
Tuppad V, Shilpa PN, Clinical trial to evaluate the addon effect of Vimlapana Karma in Dushta Vrana w.s.r. to Varicose Ulcer: A Randomised Controlled Trial. J Ayu Int Med Sci. 2024;9(12):16-27.
Available From
https://jaims.in/jaims/article/view/3876

Manuscript Received Review Round 1 Review Round 2 Review Round 3 Accepted
2024-11-12 2024-11-22 2024-12-02 2024-12-12 2024-12-24
Conflict of Interest Funding Ethical Approval Plagiarism X-checker Note
None Nil Yes 12.65

© 2024by Tuppad V, Shilpa PNand Published by Maharshi Charaka Ayurveda Organization. This is an Open Access article licensed under a Creative Commons Attribution 4.0 International License https://creativecommons.org/licenses/by/4.0/ unported [CC BY 4.0].

Download PDFBack To ArticleIntroductionAims and ObjectivesMethodologyObservation and ResultsResultsDiscussionConclusionReferences

Introduction

Varicose ulcers are the most prevalent complication of varicose veins, likely to affect many patients during their lifetime. Varicose ulcers, also referred to as venous insufficiency ulcers, venous leg ulcers, or gravitational ulcers, are a severe and debilitating consequence of chronic venous insufficiency. A chronic venous ulcer can be defined as an area of discontinuity of epidermis, persisting for four weeks or more and occurring as a result of venous hypertension and calf muscle pump insufficiency.[1]

Venous leg ulcers (VLUs) are open lesions of the lower limb and represent between 60 to 80% of all leg ulcer.[2]

It is the commonest painful condition that every patient inflicted with varicose veins and occurs by Ambulatory venous hypertension is the prime cause of venous ulcer formation. The prevalence of chronic venous ulcers in the leg is 70%-80% (2022) and Overall Incidence rate was 0.76% for males and 1.42%in females (2018).[3]

In Varicose ulcer various growth factors and inflammatory cells, which get trapped in the fibrin cuff promote severe uncontrolled inflammation in surrounding tissue preventing proper regeneration of wounds. Leukocytes get trapped in capillaries, releasing proteolytic enzymes and reactive oxygen metabolites, which cause endothelial damage. These injured capillaries become increasingly permeable to various macromolecules, accentuating fibrin deposition.[4]

Occlusion by leukocytes also causes local ischemia thereby increasing tissue hypoxia and reperfusion damage. So, it is the responsibility of surgeon that it should be cured within short period with less pain and less cost. Conservative management of varicose ulcer includes compression, stocking, elevation of limb, antibiotics usage and regular dressing of the wound.

Surgical treatments like skin grafting, sclerotherapy, laser ablation or surgical correction of superficial venous reflux practice are in use. However, recurrence of venous ulcer about 75% develop within a 3weeks and on average 60% Healed by 12 weeks. Untreated ulcers have complications like infection, loss of mobility, cellulites, gangrene and eventually lead to amputation of a limb.[5]

Varicose ulcer is correlated to Dushtavrana having classical features[6]such as Ativivruta (too wide), Atikhatina (too hard), Atiutsanna (extremely elevated), Atyushna (too hot), Pootipuyasrav (Purulent discharge), Dheergha Kalanubandi (long duration). In Sushruta Samhita (17th chapter of Sutrasthana: Aamapakveshaneeya Adhyaya[7] and 1st chapter of Chikitsa Sthana: Dwivraniya Chikitsitam Adhyaya),[8] Vimlapana Karma[9] (gentle massage) is recommended for managing Vrana Shotha (wound inflammation) and Vrana (wound).

This preliminary treatment relieves Vata-Kapha dosha obstruction, promoting wound healing by increasing local temperature, relaxing vasoconstriction, enhancing oxygenation and nutrient delivery to the wound site, removing accumulated toxins, and accelerating wound healing. To relieve such obstruction, sensitize the cells in and around the wound, and enhance the rate of wound healing, Vimlapana Karma was selected. Vimlapana Karma resolved inflammation around the wound and improved blood circulation, thereby aiding in early wound healing.

After, Vimlapana Karma Jalaukaavacharana(leech therapy) was performed. Jalaukavacharanaha[10] has its own benefits viz.-Jalauka (Leech) is anti-phlogistic, i.e. used for relief of local inflammation in tissue and has capability of improving microcirculation.

Jalaukavacharana being a bio-purificatory method removes deep seated toxins by letting out blood, clearing Srotasa and pacifying vitiated Doṣha. It is indicated in Pittaja and Raktaja Dosha conditions and act on improving the microcirculation and vasodilatation by decreasing the venous pressure hence improves tissue perfusion and help in wound healing.

Aims and Objectives

1. To evaluate the effect of Jalaukavacharana in Dushtavranas.r to Varicose ulcer.
2. To evaluate the combined effect of Vimlapana Karma and Jalaukavacharana in Dushtavranas.r to Varicose ulcer.
3. To compare the combined effect of Vimlapana Karma followed by Jalaukavacharana with Jalaukavacharana in Dushtavrana s.r to Varicose ulcer.


Hypothesis
Null Hypothesis

  • There is no significant effect of Vimlpana Karma followed by Jalaukavacharan in Dushta Vranas.r. to Varicose ulcer.
  • There is no significant effect of Jalaukavacharan in Dushta Vranas.r. to Varicose ulcer.
  • There is both group Vimlapana Karma followed by Jalaukavacharana and Jalaukavacharana in Dushta Vranas.r. to Varicose ulcer is comparable.

Alternate Hypothesis

  • There is significant effect of Vimlpana Karma followed by Jalaukavacharana in Dushta Vranas.r. to Varicose ulcer.
  • There is significant effect of Jalaukavacharana in Dushta Vranas.r. to Varicose ulcer.
  • There is both group Vimlapana Karma followed by Jalaukavacharana and Jalaukavacharana in Dushta Vranas.r. to Varicose ulcer is not comparable.

Methodology

This study was conducted between September 2023 to August 2024

Source of Data

Subjects with clinical features of Dushtavrana fulfilling the inclusion criteria approaching the OPD and IPD of Shalya tantra, Government Ayurveda and Unani Hospital, Bengaluru were selected for the study. The sample collection was initiated after post approval from the institutional ethics committee.

Sampling Design

The subjects who fulfil the inclusion criteria and complying with the informed consent (IC) were selected using method of simple random sampling.

Inclusion Criteria

  • Selection of patients is done irrespective of religion, occupation, economic and educational status.
  • Age (20 to 80year)
  • Patient presented with classical features of Dushtavrana
  • Patient presented with clinical features of varicose ulcer.

Exclusion Criteria

  • Patients with conditions like Systemic disorders, HIV, HBsAg, Burn wounds, Osteomyelitis, Gangrene, Diabetic foot ulcer, Bleeding Disorder.

Study Design

GroupsTopical TreatmentDuration
Group AJalaukavacharana 21 days
Group BVimlpana Karma f/b Jalukavacharana 21 days

Procedure

Group A: Jalaukavacharana

  • All required investigations were done.
  • Under all aseptic precautions. Vranaprakshalana done with Panchavalkala Kashaya.
  • Jatyadi Taila was applied; the wound was closed with dressing and bandage (1st to 6th day).

7th day Jalaukavacharan procedure was done.

Purvakarma

  • Jalauka was placed in a kidney tray containing Haridra Jala. Once Jalauka get activated it was considered fit for procedure.
  • Subject made to sit comfortably with extended leg and back rest. Part intended for Jalauka application was cleaned and made rough by Rubbing (Vigharshana) with dry Gauze.

Pradhan Karma

  • The Jalauka was brought into contact with the intended site. When the Jalauka was attached firmly to the intended site, it was covered with wet gauze and was moistened at intervals until the end of the procedure.
  • The Jalauka detached voluntarily; in cases where the Jalauka did not detach by itself, it was removed after 45 minutes.

Paschat Karma

  • Haemostasis was achieved by applying a pressure bandage.
  • The Jalauka Vamana procedure was carried out.
  • The patient was advised to come for daily dressing. In case of a reduction in wound size within the time period of 21 days, the patient was advised to stop further treatment.

Group B: Treated with Vimlapana Karma followed by Jalaukavacharana

Vimlapana Karma followed by Jalaukavacharana.


Vimlapana Karma
Purvakarma

  • The procedure was performed under aseptic precautions, during which gloves were worn.
  • Vranaprakshalana was performed using Panchavalkala Kashaya. The area was then wiped clean with gauze.

Pradhan Karma

  • Jatyadi Taila was applied around edge of wound.
  • According to the size of the ulcer, the palm, thumb, or pulp of fingers were used to massage around the ulcer area in a circular fashion, for a duration of 15-20 minutes.

Paschat Karma

  • After applying Jatyadi Taila, the wound was dressed and bandaged.

7th day Jalaukavacharana was done

  • Jalaukavaacharana was performed, followed by Vranaprakshalana with Panchavalkala Kashaya. Jatyadi Taila was applied, and the wound was dressed and bandaged.
  • The patient received daily dressing instructions.

In case of reduction in wound size within the time period of 21 days, then patient was advised to stop further treatment.

Duration of Treatment

Duration of treatment was 21days. Subjective and Objective parameters was assessed on before treatment (0th day), 7th day, 14th day, and 21st day

Statistical design

Statistical test for within groups Wilcoxon signed rank test –for all parameters. Statistical test for between the groups Mann Whitney ‘U’ test –for all parameters. The differences in the mean values were considered, the corresponding p value was noted, and the results obtained were interpreted as Highly significant at p<0.001 and p<0.01, significant at p<0.05

Assessment Criteria

Assessment of study was done before treatment, during & after treatment & at follow-up on basis of assessment parameters as per case proforma

Bates-Jensen Criteria for Wound Assessment

Gradation of Parameters

Size

Grade 1 - Length X Width < 4sq.cm
Grade 2 - Length X Width 4 -< 16sq.cm
Grade 3 - Length X Width 16.1 -< 36sq.cm
Grade 4 - Length X Width 36.1 -< 80sq.cm
Grade 5 - Length X Width > 80sq.cm.

Edge

Grade 1 - Indistinct, diffuse, none clearly visible.
Grade 2 - Distinct, outline clearly visible, attached, even with wound base.
Grade 3 - Well defined, not attached to wound base.
Grade 4 - Well defined, not attached to base, rolled under, thickened.
Grade 5 - Well defined, fibrotic, scarred or hyperkeratosis.

Exudate Type

Grade 1 - None.
Grade 2 - Bloody
Grade 3 - Serosanguineous, thin, watery, pale, red /pink.
Grade 4 - Serous, thin, watery, clear.
Grade 5 - Purulent, thin or thick, opaque, tan/yellow, with or without odor.

Skin Colour Surrounding Area

Grade 1 - Pink or normal for an ethnic group.
Grade 2 - Bright red &/or blanches to touch.
Grade 3 - White or grey pallor or hypo pigmented.
Grade 4 - Dark red or purple &/or non-bleachable
Grade 5 - Black or hyper pigmented.

Granulation Tissue

Grade1 - Skin intact or partial thickness wound.
Grade 2 - Bright, beefy red; 75% to 100% of wound filled &/or tissue over growth.
Grade 3 - Bright, beefy red; 75%to>25%0f wound.
Grade 4 - Pink, &/or dull, dusky red &/or fills<25% of wound.
Grade 5 - No granulation tissue present.

Observation and Results

Clinically diagnosed 40 subjects of Dushta Vrana w.s.r. to Varicose ulcer were randomly selected and assigned in two groups of 20 subjects each for study. Group-A was treated with Jalaukavacharana followed by daily dressing for a period of 21 days and Group-B was treated with Vimlapana Karama followed by Jalaukavacharana and daily dressing for 21 days.


Observation of Patients profile

The study found that both groups had a similar distribution in terms of gender (p=1.000), socioeconomic status (p=0.33), occupation (p=0.07), diet (p=0.05), and a family history of Varicose vein or ulcer (p=1.00). There were significant differences in the age distribution (p=0.77), mean ulcer chronicity (p=0.82), Affected limb(p=0.32), and position of ulcer (p=0.28).

Results

1. Effect on Size

Table 1: Effect of treatment on Size (between the group)

VariableGroupNMean RankSum of RanksMann-Whitney UP-ValueResult
SizeGroup A2013.60272.0062.0000.00004Sig
Group B2027.40548.00
Total40

The study data indicates that, effect of therapy on size of the ulcer before and after the intervention between the group showed significant difference(p<0.001) favouring towards group B (with higher mean change of 27.40).

Table 2: Effect of treatment on Size (within the group)

SizeMeanMedianSDSEWilcoxon ZP-Value% EffectResult
Group ABT2.853.000.880.20----
Day 72.853.000.880.20.000b1.0000000.00NS
Day 142.702.000.920.21-1.732c0.0832655.26NS
Day 212.452.000.830.18-2.530c0.01141214.04Sig
Group BBT3.053.000.760.17----
Day 73.003.000.730.16-1.000b0.3173111 .64NS
Day 142.352.000.670.15-3.500b0.00046522.95Sig
Day 211.752.000.550.12-4.130b0.00003642.62Sig

Effect of therapy on size within the group analysis on size of the ulcer different time interval showed that, group A had shown significant changes on 21st day of intervention(p=0.01), whereas group B showed significant changes on 14th(p<0.001) and 21st(p<0.001) day of intervention.

2. Effect on Edge

Table 3: Effect of treatment on Edge (between the group)

VariableGroupNMean RankSum of RanksMann-Whitney UP-ValueResult
EdgeGroup A2013.20264.0054.0000.00001Sig
Group B2027.80556.00
Total40

Based on trialresults, group B (with a larger mean change of 27.80) prevailed in significant difference (p<0.001) between intervention effect on ulcer's edge preceding and following intervention.

Table 4: Effect of treatment on Edge (within group)

EdgeMeanMedianSDSEWilcoxon ZP-Value% EffectResult
Group ABT3.353.000.590.13----
Day 73.353.000.590.13.000b1.0000000.00NS
Day 142.653.000.670.15-3.742c0.00018320.90Sig
Day 212.452.500.600.14-4.243c0.00002226.87Sig
Group BBT3.604.000.600.13----
Day 73.203.000.520.12-2.828b0.00467811.11Sig
Day 142.502.500.510.11-3.947b0.00007930.56Sig
Day 211.802.000.520.12-4.035b0.00005550.00Sig

The edge of ulcer statistical analysis revealed that group A had significant changes on 14th day of intervention (p<0.01), while group B showed significant changes on the 7th, 14th, and 21st days of the intervention (p<0.001), respectively.

3. Effect on the Exudate Type

Table 5: Effect of treatment on Exudate type (between the group)

VariableGroupNMean RankSum of RanksMann-Whitney UP-ValueResult
Exudate typeGroup A2016.75335.00125.0000.01418Sig
Group B2024.25485.00
Total40

The research findings demonstrate that treatment impact on ulcer exudate type from before to after intervention differed significantly (p<0.05),preferring group B (whose mean change increased at 24.25).


Table 6: Effect of treatment on Exudate type (within the group)

Exudate typeMeanMedianSDSEWilcoxon ZP-Value% EffectResult
Group ABT3.553.000.690.15----
Day 72.903.000.850.19-3.606c0.00031118.31Sig
Day 142.302.000.980.22-3.852c0.00011735.21Sig
Day 211.751.000.910.20-4.035c0.00005550.70Sig
Group BBT3.253.000.440.10----
Day 72.402.000.500.11-4.123b0.00003726.15Sig
Day 141.351.000.490.11-4.177b0.00003058.46Sig
Day 211.001.000.000.00-4.134b0.00003669.23Sig

According to the data analysis of the ulcer exudate, group B revealed substantial changes on day 7th of the intervention (p<0.001), whereas group A exhibited significant changes on day 7th (p<0.001).

4. Effect on the Skin Colour Surrounding Area

Table 7: Effect of treatment on Skin colour surrounding area (between the group)

VariableGroupNMean RankSum of RanksMann-Whitney UP-ValueResult
Skin colour surrounding areaGroup A2017.55351.00141.0000.02218Sig
Group B2023.45469.00
Total40

Table 8: Effect of treatment on Skin colour surrounding area (within the group)

Skin colour surrounding areaMeanMedianSDSEWilcoxon ZP-Value% EffectResult
Group ABT4.655.000.750.17----
Day 74.605.000.820.18-1.000c0.3173111.08NS
Day 144.605.000.820.18-1.000c0.3173111.08NS
Day 214.555.000.940.21-1.000c0.3173112.15NS
Group BBT4.555.000.890.20----
Day 74.305.001.030.23-1.890b0.0587825.49NS
Day 144.155.001.270.28-2.271b0.0231418.79Sig
Day 213.955.001.570.35-2.401b0.01635113.19Sig

The group analysis pertaining to the changes ofskin colour surrounding the ulcer at different time intervals revealed that group B exhibited substantial changes on the 14th (p<0.05) and 21st (p<0.05) day of intervention, while group A showed no significant changes on the 21st day of intervention (p>0.05).

5. Effect on Granulation Tissue

Table 9: Effect of treatment on Granulation tissue (between the group)

VariableGroupNMean RankSum of RanksMann-Whitney UP-ValueResult
Granulation tissueGroup A2014.43288.5078.5000.00009Sig
Group B2026.58531.50
Total40

The study findings indicate that group B had a greater mean change of 26.58 and was superior in terms of a significant difference (p<0.001) between the intervention effect on the granulation tissue of the ulcer before and after the intervention.

Table 10: Effect of treatment on Granulation tissue (within the group)

Granulation tissueMeanMedianSDSEWilcoxon ZP-Value% EffectResult
Group ABT3.654.000.490.11----
Day 73.604.000.500.11-1.000c0.3173111.37NS
Day 142.953.000.510.11-3.742c0.00018319.18Sig
Day 212.603.000.600.13-4.379c0.00001228.77Sig
Group BBT3.654.000.490.11----
Day 73.403.000.500.11-2.236b0.0253476.85Sig
Day 142.452.000.510.11-4.179b0.00002932.88Sig
Day 211.852.000.490.11-3.999b0.00006449.32Sig

Table 11: Total Percentage of Improvement observed in Group A and Group B

Parameter% Effect
Group AGroup B
Size14.0442.62
Edge26.8750.00
Exudate type50.7069.23
Skin colour surrounding area2.1513.19
Granulation tissue28.7749.32
Average % Effect24.5044.87

In the group analysis, substantial changes were observed in the granulation tissue of the ulcer on day 14 (p=0.001), while group B showed significant changes on day 7 (p<0.05), day 14, and day 21 (p<0.001) of the intervention.

Top of FormGroup B outperformed Group A in ulcer healing, with a 42.62% reduction in ulcer size compared to 14.04%. Group B also showed greater improvements in ulcer edge (50% vs 26.87%), exudate type (69.23% vs 50.70%), skin color (13.19% vs 2.15%), and granulation tissue (49.32% vs 28.77%). Overall, Group B had a 44.87% improvement, while Group A had 24.50%, indicating more effective treatment in Group B.

jaims_3876_01.JPG
Graph 1: Overall Effect of treatment on Group A and Group B

Discussion

Discussion of demographic data

This study found that varicose veins and ulcers commonly begin after age 20, with a peak in fourth decade. Among participants, 97.05% were male, though historical data suggests women may also be predisposed due to pregnancy and hormones. Most participants were middle-class (50%) or lower-middle-class (45%), with 75% engaged in occupations involving prolonged standing or sedentary work, contributing to poor circulation and delayed healing. Mixed diets were prevalent (80%), with vegetarian diets potentially aiding wound healing. Family history was absent in 85% of cases, highlighting lifestyle as a major factor. The right limb was most affected (45%), followed by the left (30%) and bilateral cases (25%),

with chronicity ranging from less than a year (42.07%) to over five years (7.05%). Ulcers were common at the medial malleolus (50%), and both solitary and multiple ulcers were equally distributed, reflecting the need for timely, personalized management to prevent complications.

Discussion on Results

Effect on Size: According to the study, Group B (Jalaukavacharana and Vimlapana Karma) significantly performed Group A (Jalaukavacharana) with a 42.62% reduction in ulcer size. A comparison for the groups showed p<0.05, signifying more effective results, while Group B showed a highly significant effect (p<0.001).

Although it affects slower, Jalaukavacharana alone minimises toxins and inflammation. By minimising vasoconstriction, enhancing neovascularisation, and accelerating up recovery, the combination treatment in Group B, on the opposite hand, enhanced healing and was more successful in decreasing ulcer size.

Effect on Edge: In the study, Group A (Jalaukavacharana) showed a 26.87% improvement in wound edge healing, while Group B (Vimlapana Karma and Jalaukavacharana) showed 50% improvement. Both therapies promote wound contraction through fibroblasts and collagen. Jalaukavacharana enhances tissue penetration and toxin removal. In Group B, the combination therapy boosts circulation and reduces inflammation, while Jalaukavacharana accelerates microcirculation, promoting faster wound edge healing in chronic varicose ulcers.

Effect on Edge: Significant improvements in exudate type were shown by Group A (Jalaukavacharana) and Group B (Vimlapana Karma and Jalaukavacharana), with Group A demonstrating a 50.70% improvement and Group B a 69.23% improvement. While Vimlapana Karma cures the underlying cause by purifying blood and minimising inflammation, Jalaukavacharana decreases exudates by harmonising doshas and improving venous function. The combination accelerates wound healing effectively decreases exudate.

Effect on Skin colour of Surrounding area: Skin colour did not change significantly in Group A (Jalaukavacharana) (2.15%, p > 0.05), but it did significantly improve in Group B (Vimlapana Karma and Jalaukavacharana) (13.19%, p < 0.05).


While Group B's healing might be result of Vimlapana Karma's improvement of circulation, re-epithelialization, and blood purification, which encouraged healing and decreased inflammation, Group A's lack of change may be explained by gradual effect of leech therapy.

Effect on Granulation tissues: Granulation tissue in Group A (Jalaukavacharana) and Group B (Vimlapana Karma and Jalaukavacharana) improved significantly; Group A's improvement was 28.77%, while Group B's was 49.32%. By increasing effectiveness of its components, Jalaukavacharana improves granulation and lowers inflammation in Group A. Vimlapana Karma from Group B enhances tissue healing and circulation by stimulating growth of healthy granulation tissue.

Probable mode of action of Vimlapana Karma:

Vimlapana Karma in Dushta Vrana facilitates wound healing by relieving local vasoconstriction, improving circulation at wound site, and enhancing oxygen supply. This is where mechanotransduction—a key process—comes into play. Mechanotransduction is conversion of a mechanical stimulus into a biochemical response within cells. In context of wound healing, mechanical forces from actions like massage stimulate cells, prompting signalling pathways that enhance tissue repair and regeneration11. Studies show that massage acts as an immune modulator, influencing neutrophils' apoptotic signalling, reducing release of proinflammatory cytokines12, and promoting tissue repair. Additionally, mechanical pressure during massage increases local temperature, improving blood flow by relieving vasoconstriction and carrying essential nutrients, oxygen, and insulin to wound site. This improved circulation aids in alleviating anoxic condition of wound. Mechanotransduction also promotes release of beta-endorphins, which provide pain relief13. With improved blood flow and nutrient delivery, epithelial cell regeneration is accelerated, leading to faster healing of extracellular matrix (ECM)—a critical component in dermal repair, particularly for varicose ulcers.

Conclusion

The study found that most participants were male, aged 41-50, predominantly, followed a mixed diet, and had varicose ulcers with a chronicity of 1 to 5 years.

Before and After treatment in Group-A

jaims_3876_02.JPG
Before treatment

jaims_3876_03.JPG
During treatment Vimlapana Karma

Group B (Vimlapana Karma followed by Jalaukavacharana) was more effective in managing varicose ulcers, showing significant improvements in ulcer size, edge, exudate type, skin color, and granulation tissue compared to Group A (Jalaukavacharana). Group B consistently outperformed Group A, with an average improvement of 44.87% in Group B versus 24.50% in Group A. Statistically significant differences were observed at all time points (BT, Day 7, Day 14, and Day 21),


with Group B demonstrating superior results. No adverse effects were reported in either group. The study supports the hypothesis that Vimlapana Karmaprovides a significant added benefit to Jalaukavacharana. Vimlapana Karma is a cost-effective, feasible, and simple procedure with minimal equipment requirements and no complications, confirming its significant role in enhancing the treatment of varicose ulcers.

jaims_3876_04.JPG
During Jalaukavacharana

jaims_3876_05.JPG
After treatment

Before and After treatment in Group-B

jaims_3876_06.JPG
Before treatment

jaims_3876_07.JPG
7th day Jalaukavacharana

jaims_3876_08.JPG
After treatment

References

1. WHO Library Cataloguing in Publication Data. Wound and lymphoedema management. 2010. Edited by John M. Macdonald, Mary Jo Geyer, Laura L. Bolton. New Jersey: University of Medicine and Dentistry of New Jersey, Department of Surgery (Bioengineering).


2. Probst S, Weller CD, Bobbink P, Saini C, Pugliese M, Skinner MB, Gethin G. Prevalence and incidence of venous leg ulcers - a protocol for a systematic review. Syst Rev. 2021 May 12;10(1):148. doi:10.1186/s13643-021-01697-3. PMID:33980324; PMCID:PMC8117489.

3. Margolis DJ, Bilker W, Santanna J, Baumgarten M. Venous leg ulcer: Incidence and prevalence in the elderly. J Am Acad Dermatol. 2002;46(3):381-6. doi: 10.1067/mjd.2002.121739.

4. O'Connell PR, McCaskie AW, Sayers RD, editors. Bailey & Love’s Short Practice of Surgery. 28th ed. Boca Raton: CRC Press, Taylor & Francis Group; 2023.

5. Bland KI, Sarr MG, Wong J. Principles of Surgery. 10th ed. New York: McGraw-Hill Education; 2012. p. 264.

6. Acharya S, editor. Sushruta Samhita with Nibandha Sangraha commentary of Sri Dalhanacharya. 6th ed. Varanasi: Chaukambha Surabharati Prakashan; 2010. Sutra Sthana, Chapter-22, Verse-8, pp. 824, p. 109.

7. Acharya S, editor. Sushruta Samhita with commentary of Dalhana. Reprint. Varanasi: Chaukambha Publications; 2006. Chapter-17.

8. Acharya S, editor. Sushruta Samhita with Nibandha Sangraha commentary of Sri Dalhanacharya. Reprint. Varanasi: Chaukambha Surabharati Prakashan; 2010. Chikitsa Sthana, Chapter-1.

9. Acharya S, editor. Sushruta Samhita with Nibandha Sangraha commentary of Sri Dalhanacharya. Reprint. Varanasi: Chaukambha Surabharati Prakashan; 2010. Chikitsa Sthana, Chapter-1, Verse-22-23, pp. 824, p. 395.

10. Acharya S, Acharya N, editors. Sushruta Samhita with Nibandhasaarasangraha Commentary of Shree Dhalhana Acharya and Nyaaya Candrikaakhya Panjika Vyaakhyaa of Shree Gayaadas Acharya. 6th ed. Varanasi: Chaukambha Sanskrit Sansthan; 2017. Sutra Sthana, Chapter-13, Shloka-24, p. 58.

11. Wang N, Tytell JD, Ingber DE. Mechanotransduction at a distance: mechanically coupling the extracellular matrix with the nucleus. Nat Rev Mol Cell Biol. 2009;10(1):75-82.

12. Waters-Banker C, Tuttle N, Hammer W, Pfeiffer J. Investigating the Mechanisms of Massage Efficacy: The Role of Mechanical Immunomodulation. J Bodyw Mov Ther. 2014;18(3):456-65.

13. Shin TM, Bordeaux JS. The role of massage in scar management: A literature review. Dermatol Surg. 2012;38(3):414-23.

Disclaimer / Publisher's NoteThe statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of Journals and/or the editor(s). Journals and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.